CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
15+ Premium newsletters from leading experts
，这一点在谷歌浏览器【最新下载地址】中也有详细论述
18 February 2026ShareSave
Сайт Роскомнадзора атаковали18:00
About half of all churches in England have bats in them